Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Ego Pharmaceuticals Pty. Ltd.
Sunrise For Sunscreen Innovation Act – FDA Seeks Comment On TEA Decisions
Under the Sunscreen Innovation Act, FDA’s tentative determinations on sunscreen ingredients TEAs are deemed proposed orders and must be made available for comment. The agency seeks input on six insufficient-data letters issued to sunscreen TEA sponsors in 2014.
Sunrise For Sunscreen Innovation Act – FDA Seeks Comment On TEA Decisions
Under the Sunscreen Innovation Act, FDA’s tentative determinations on sunscreen ingredients TEAs are deemed proposed orders and must be made available for comment. The agency seeks input on six insufficient-data letters issued to sunscreen TEA sponsors in 2014.
FDA Seeks Comment On Proposed Orders Under Sunscreen Innovation Act
Under the Sunscreen Innovation Act enacted in late 2014, FDA’s tentative determinations on time and extent applications for sunscreen ingredients are now deemed proposed orders and must be made available for public comment. The agency seeks input on six insufficient-data letters issued to sunscreen TEA sponsors in 2014, including its latest to BASF regarding bemotrizinol, marketed as Tinosorb S.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice